Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenoterol 1.25mg/Ipratropium 500microg/4ml neb liq ud vials
0301040M0AAABAB
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 100microg/dose / Ipratropium 40microg/dose inh
0301040M0AAAAAA
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 100microg/Ipratropium bromide 40microg/dose BA inh
0301040M0AAACAC
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
|
Fenoterol 50microg/Ipratropium brom 20microg/dose CFC free
0301040M0AAADAD
|
Fenoterol hydrobromide/ipratropium | Fenoterol hydrobromide | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.